T cell proliferation and cancer cell killing assays

MM Martina Musella
AG Andrea Guarracino
NM Nicoletta Manduca
CG Claudia Galassi
ER Eliana Ruggiero
AP Alessia Potenza
EM Ester Maccafeo
GM Gwenola Manic
LM Luca Mattiello
SR Sara Soliman Abdel Rehim
MS Michele Signore
MP Marco Pietrosanto
MH Manuela Helmer-Citterich
MP Matteo Pallocca
MF Maurizio Fanciulli
TB Tiziana Bruno
FN Francesca De Nicola
GC Giacomo Corleone
AB Anna Di Benedetto
CE Cristiana Ercolani
EP Edoardo Pescarmona
LP Laura Pizzuti
FG Francesco Guidi
FS Francesca Sperati
SV Sara Vitale
DM Daniele Macchia
MS Massimo Spada
GS Giovanna Schiavoni
FM Fabrizio Mattei
AN Adele De Ninno
LB Luca Businaro
VL Valeria Lucarini
LB Laura Bracci
EA Eleonora Aricò
GZ Giovanna Ziccheddu
FF Francesco Facchiano
SR Stefania Rossi
MS Massimo Sanchez
AB Alessandra Boe
MB Mauro Biffoni
RM Ruggero De Maria
IV Ilio Vitale
AS Antonella Sistigu
request Request a Protocol
ask Ask a question
Favorite

UV-irradiated MCA205-OVA as in ref. 59 were cocultured with BM-derived DCs (2:1 ratio, 24 h). DCs were cultured (5:1 ratio, 72 h) with splenic purified CD8+OT-1 cells. Cross-primed CD8+OT-1 cells were labeled with carboxyfluorescein succinimidyl ester (CFSE) dye (1 µM, 10 min, 37 °C) and restimulated with live PAR or CD44L MCA205-OVA cells (1:5 ratio, 3 days) before cytofluorometric CFSE level analysis on live-gated CD8+ cells and PI level analysis on CD45 cells.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A